Oxford Financial Group LTD Bristol Myers Squibb CO Transaction History

Oxford Financial Group LTD

$1.76 Billion
Q3 2025

A detailed history of Oxford Financial Group LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oxford Financial Group LTD holds 4,836 shares of BMY stock, worth $226,373. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,836

Previous 4,836 -0.0%

Holding current value

$226,373

Previous $223,000 2.24%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$44.12 - $59.6 $3,926 - $5,304	-89 Reduced 1.81%	4,836 $223,000
Q1 2025 May 15, 2025	SELL	$53.9 - $63.11 $16,762 - $19,627	-311 Reduced 5.94%	4,925 $300,000
Q4 2024 Feb 11, 2025	BUY	$51.92 - $59.94 $7,788 - $8,991	150 Added 2.95%	5,236 $296,000
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $80,827 - $105,466	-2,038 Reduced 28.61%	5,086 $263,000
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $7,406 - $9,750	184 Added 2.65%	7,124 $295,000

Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $31,282 - $35,468	-652 Reduced 8.59%	6,940 $376,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $193 - $231	4 Added 0.05%	7,592 $389,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $69,120 - $77,287	-1,194 Reduced 13.6%	7,588 $440,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $47,272 - $52,489	742 Added 9.23%	8,782 $561,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $45,865 - $52,021	698 Added 9.51%	8,040 $557,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $20,407 - $24,164	298 Added 4.23%	7,342 $528,000
Q3 2022 Nov 02, 2022	SELL	$0.13 - $76.84 $270 - $159,904	-2,081 Reduced 22.81%	7,044 $501,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $156,060 - $171,877	2,149 Added 30.81%	9,125 $703,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $56,500 - $67,748	919 Added 15.17%	6,976 $509,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $14,104 - $16,442	263 Added 4.54%	6,057 $378,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $19,940 - $23,357	337 Added 6.18%	5,794 $343,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $849,511 - $955,449	-14,316 Reduced 72.4%	5,457 $345,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $25,867 - $29,312	448 Added 2.32%	19,773 $1.23 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $3,388 - $3,754	59 Added 0.31%	19,325 $1.17 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $8,277 - $9,677	-151 Reduced 0.78%	19,266 $1.13 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $900,948 - $1.31 Million	19,417 New	19,417 $1.08 Million

Others Institutions Holding BMY

# of Institutions

2,717

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.

Account

Oxford Financial Group LTD Bristol Myers Squibb CO Transaction History